|
Volumn 94, Issue 9, 2001, Pages 967-974
|
Hypertrophic cardiomyopathy: Long-term clinical outcome in a regional cohort of 243 patients;Cardiomyopathie hypertrophique: Evolution clinique à long terme d'une cohorte régionale de 243 patients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMIODARONE;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM ANTAGONIST;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DISOPYRAMIDE;
DIURETIC AGENT;
VERAPAMIL;
ADULT;
AGED;
ARTICLE;
CAUSE OF DEATH;
CEREBROVASCULAR ACCIDENT;
DEFIBRILLATION;
ECHOCARDIOGRAPHY;
FEMALE;
FOLLOW UP;
FUNCTIONAL ASSESSMENT;
HEART FAILURE;
HEART PACING;
HEART TRANSPLANTATION;
HEART VENTRICLE SEPTUM;
HUMAN;
HYPERTROPHIC CARDIOMYOPATHY;
MAJOR CLINICAL STUDY;
MALE;
MORTALITY;
MULTIVARIATE ANALYSIS;
MYOMECTOMY;
ONSET AGE;
OUTCOMES RESEARCH;
RISK FACTOR;
SUDDEN DEATH;
THICKNESS;
ADULT;
CARDIOMYOPATHY, HYPERTROPHIC;
DEATH, SUDDEN, CARDIAC;
DEFIBRILLATORS, IMPLANTABLE;
FEMALE;
HEART TRANSPLANTATION;
HUMANS;
MALE;
MIDDLE AGED;
PACEMAKER, ARTIFICIAL;
PROGNOSIS;
RETROSPECTIVE STUDIES;
RISK FACTORS;
TREATMENT OUTCOME;
|
EID: 0035574797
PISSN: 00039683
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (30)
|